Successful Treatment of Suspected Cannabinoid Hyperemesis Syndrome Using Haloperidol in the Outpatient Setting
Chronic use of cannabis can result in a syndrome of hyperemesis characterized by cyclical vomiting without any other identifiable causes. Cannabinoid hyperemesis syndrome (CHS) is seldom responsive to traditional antiemetic therapies. Despite frequent nausea and vomiting, patients may be reluctant t...
Saved in:
| Main Authors: | Jennifer L. Jones, Karen E. Abernathy |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2016-01-01
|
| Series: | Case Reports in Psychiatry |
| Online Access: | http://dx.doi.org/10.1155/2016/3614053 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Haloperidol as a treatment option in cannabinoid
hyperemesis syndrome
by: Peter Stawinski, et al.
Published: (2022-12-01) -
Cannabinoid Hyperemesis
by: Joseph V. Pergolizzi Jr., et al.
Published: (2018-11-01) -
Cannabinoid hyperemesis syndrome: A review
by: R.A. Jiménez-Castillo, et al.
Published: (2025-04-01) -
Cannabinoid Hyperemesis Syndrome - case report
by: Maria Mazurek-Staroń, et al.
Published: (2025-05-01) -
Droperidol Plus Diphenhydramine for Symptom Improvement in Suspected Cannabinoid Hyperemesis Syndrome: A Prospective Cohort Study
by: Chopra Q, et al.
Published: (2024-11-01)